GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Valiant Laboratories Ltd

Valiant Laboratories: FY26 Standalone Net Profit Rs. 554.82 Lakhs

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 14 May 2026, 07:18 PM IST  ·  BSE ID: bb2a91b8-b7d3-424d-a01d-f6033ff66316
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board approved its financial results, showing an annual standalone net profit of Rs. 554.82 Lakhs.
🤖 AI Summary
  • Board approved Audited Standalone and Consolidated Financial Results for Q4 FY26 and full FY26.
  • Standalone Net Profit for the year ended March 31, 2026, was Rs. 554.82 Lakhs.
  • Standalone Revenue from Operations for FY26 reported at Rs. 21,704.25 Lakhs.
  • The financial results were reviewed by the Audit Committee and approved by the Board.
  • Meeting of the Board of Directors was held on May 14, 2026, to consider and approve these results.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Standalone Revenue from Operations (Year Ended)
Rs. 21,704.25 Lakhs
62.75%
Standalone Net Profit/(Loss) (Year Ended)
Rs. 554.82 Lakhs
Not comparable — limited prior period data.
Standalone Revenue from Operations (Quarter Ended)
Rs. 6,530.34 Lakhs
13.04%
Standalone Net Profit/(Loss) (Quarter Ended)
Rs. 353.28 Lakhs
9.09%
Paid up equity share capital
Rs. 5,431.25 Lakhs
Basic Earning per equity share (Year Ended)
Rs. 1.02
Not comparable — limited prior period data.
🏢 How This Affects the Company
📈
Business Impact
The company reported a standalone revenue from operations of Rs. 21,704.25 Lakhs for FY26, indicating sales performance over the year.
💰
Financial Impact
The standalone net profit for FY26 reached Rs. 554.82 Lakhs, a turnaround from a net loss of Rs. (215.02) Lakhs in the prior year.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results disclosure.
👤
Who Is Affected
All shareholders are affected as the audited financial results provide an overview of the company's financial performance for the year ended March 31, 2026, including a net profit of Rs. 554.82 Lakhs.
🔍
Management Signal
Management confirms the company's financial performance for the fiscal year and the fourth quarter, transitioning to net profitability in standalone results.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q1 FY27 financial results filing to assess ongoing performance trends.
Any further announcements regarding operational expansion or business initiatives.
Investor conference call transcripts for detailed management commentary on results.
LOW RISK The filing reports annual audited financial results showing a return to profitability.
💡 Investor Takeaway
Valiant Laboratories reported standalone net profit of Rs. 554.82 Lakhs for FY26, a turnaround from a loss of Rs. (215.02) Lakhs in FY25. Revenue from Operations for FY26 increased to Rs. 21,704.25 Lakhs.
⚖️ Strengths & Concerns

✅ Positives

  • Standalone Net Profit for FY26 was Rs. 554.82 Lakhs, improving from a loss of Rs. (215.02) Lakhs in FY25.
  • Standalone Revenue from Operations for FY26 increased to Rs. 21,704.25 Lakhs from Rs. 13,336.18 Lakhs in FY25.
📅 Company Track Record
Valiant Laboratories' previous filing on May 14, 2026, also highlighted the FY26 standalone net profit of Rs. 554.82 Lakhs. The company's board had met on May 14, 2026, to approve these results. The company was incorporated in 2021 and recently listed via IPO on October 06, 2023.

Based on publicly available historical data. For context only.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.